The raw feed
Latest filings
Every transaction from every Form 4, as filed, newest first. Open-market buys (P) and sells (S) become signals; the rest is shown for completeness.
| Date | Company | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|---|
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -58,065 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -17,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Deepika Pakianathan director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -91,204 | - | - | 6,009 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Ordinary Shares | -6,009 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -6,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -28,000 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -22,044 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -23,576 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -24,258 | - | - | 0 | 20 d ago |
| Sep 23, 2026 | TBPH Theravance Biopharma, Inc. | Dean J Mitchell director | DDisposition to issuer Share Option (Right to Buy)derivative | -13,398 | - | - | 0 | 20 d ago |
| Sep 22, 2026 | MS MORGAN STANLEY | Mitsubishi Ufj Financial Group Inc owner | DDisposition to issuer Common Stock10b5-1 | -1,340,519 | $212.57 | $285M | 375,330,252 | 20 d ago |
| Sep 23, 2026 | CCG Cheche Group Inc. | Liqun Li director | DDisposition to issuer Class A Ordinary Shares | -156 | $0.00 | $0 | 0 | 21 d ago |
| Sep 23, 2026 | CCG Cheche Group Inc. | Liqun Li director | DDisposition to issuer Restricted Shares | -15 | $0.00 | $0 | 0 | 21 d ago |
| Sep 23, 2026 | CCG Cheche Group Inc. | Shengwen Rong director | DDisposition to issuer Class A Ordinary Shares | -312 | $0.00 | $0 | 0 | 21 d ago |
| Sep 23, 2026 | CCG Cheche Group Inc. | Shengwen Rong director | DDisposition to issuer Restricted Shares | -30 | $0.00 | $0 | 0 | 21 d ago |
| Sep 23, 2026 | CCG Cheche Group Inc. | Xiufang LI director | DDisposition to issuer Restricted Shares | -171 | $0.00 | $0 | 0 | 21 d ago |
| Aug 19, 2026 | SWMR Swarmer, Inc | Serhii Kupriienko See Remarks | DDisposition to issuer Common Stock | -1,202,065 | $0.00 | $0 | 4,137,537 | 21 d ago |
| Sep 19, 2026 | PRTH Priority Technology Holdings, Inc. | Tim O'Leary Chief Financial Officer | DDisposition to issuer Common Stock | -27,352 | $5.83 | $159k | 329,286 | 22 d ago |
| Sep 18, 2026 | LUNR Intuitive Machines, Inc. | Timothy Price Crain II SVP & Chief Technology Officer | DDisposition to issuer Class C Common Stock10b5-1 | -100,000 | - | - | 8,620,615 | 22 d ago |
| Sep 21, 2026 | LUNR Intuitive Machines, Inc. | Timothy Price Crain II SVP & Chief Technology Officer | DDisposition to issuer Class C Common Stock10b5-1 | -50,000 | - | - | 8,570,615 | 22 d ago |
| Sep 18, 2026 | CCHH CCH Holdings Ltd | Kok E Goh Chairman and CEO and COO | DDisposition to issuer Class A Ordinary Shares | -347,500 | $0.00 | $0 | 0 | 23 d ago |
| Sep 18, 2026 | CCHH CCH Holdings Ltd | Hui-Chen Hsu Co-CEO | DDisposition to issuer Class A Ordinary Shares | -1,319,500 | $0.00 | $0 | 0 | 23 d ago |
| Sep 17, 2026 | SION Sionna Therapeutics, Inc. | Jennifer Fitzpatrick CLO and Head of Program Mgmt. | DDisposition to issuer Non-Qualified Stock Option (right to buy)derivative | -103,140 | $0.00 | $0 | 0 | 26 d ago |
| Sep 17, 2026 | REAX Real REMAX Group Inc. | Alexandra Lumpkin Chief Legal Officer | DDisposition to issuer Restricted Stock Unitsderivative | -98 | $0.00 | $0 | 800 | 26 d ago |
| Sep 17, 2026 | SION Sionna Therapeutics, Inc. | Charlotte McKee CMO and Head of R&D | DDisposition to issuer Non-Qualified Stock Option (right to buy)derivative | -155,700 | $0.00 | $0 | 0 | 26 d ago |
| Sep 17, 2026 | REAX Real REMAX Group Inc. | Jenna Rozenblat President | DDisposition to issuer Restricted Stock Unitsderivative | -333 | $0.00 | $0 | 1,500 | 26 d ago |
| Sep 17, 2026 | SION Sionna Therapeutics, Inc. | Elena Ridloff CFO and CBO | DDisposition to issuer Non-Qualified Stock Option (right to buy)derivative | -165,440 | $0.00 | $0 | 0 | 26 d ago |
| Sep 17, 2026 | SION Sionna Therapeutics, Inc. | Michael Cloonan President & CEO | DDisposition to issuer Non-Qualified Stock Option (right to buy)derivative | -436,100 | $0.00 | $0 | 0 | 26 d ago |
| Sep 16, 2026 | UGP ULTRAPAR HOLDINGS INC | Decio de Sampaio Amaral CEO Hidrovias | DDisposition to issuer Restricted Sharesderivative | -140,000 | $0.00 | $0 | 961,127 | 26 d ago |
| Apr 20, 2026 | UGP ULTRAPAR HOLDINGS INC | Decio de Sampaio Amaral CEO Hidrovias | DDisposition to issuer Restricted Sharesderivative | -78,824 | $0.00 | $0 | 1,101,127 | 26 d ago |
| Sep 16, 2026 | NFG NATIONAL FUEL GAS CO | Joseph N Del Vecchio President, NFG Supply Corp. | DDisposition to issuer Common Stock | -428 | - | - | 16,017 | 27 d ago |
| Sep 16, 2026 | NFG NATIONAL FUEL GAS CO | Martin A Krebs Chief Information Officer | DDisposition to issuer Common Stock | -478 | - | - | 4,164 | 27 d ago |
| Sep 16, 2026 | ISCO International Stem Cell CORP | Paul Maier V director | DDisposition to issuer Stock Optionsderivative | -30,000 | $0.00 | $0 | 0 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Emily Nachlas Chief Risk Officer | DDisposition to issuer Common Stock | -72 | $79.03 | $5,690 | 16,575 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Emily Nachlas Chief Risk Officer | DDisposition to issuer Common Stock | -53 | $79.03 | $4,189 | 16,575 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Emily Nachlas Chief Risk Officer | DDisposition to issuer Common Stock | -64 | $79.03 | $5,058 | 16,575 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Barbara Kennedy Chief Human Resources Officer | DDisposition to issuer Common Stock | -101 | $79.03 | $7,982 | 10,332 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Barbara Kennedy Chief Human Resources Officer | DDisposition to issuer Common Stock | -74 | $79.03 | $5,848 | 10,332 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Barbara Kennedy Chief Human Resources Officer | DDisposition to issuer Common Stock | -82 | $79.03 | $6,480 | 10,332 | 27 d ago |
| Sep 15, 2026 | WAL WESTERN ALLIANCE BANCORPORATION | Timothy W Boothe Chief Administration Officer | DDisposition to issuer Common Stock | -97 | $79.03 | $7,666 | 65,417 | 27 d ago |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.